On Mar. 2, 2015, Dr. Helen Wallace, a world-renowned professor, mentor and advocate known for her passion for…
On Jan. 23, 2015, the U.S. Centers for Disease Control and Prevention (CDC) Health Alert Network issued a…
On Jan. 12, 2015, The Albert Einstein Cancer Center became the only medical institution in New York City,…
In 2015, the California Life Sciences Association was founded. (CLSA) was founded when the Bay Area Bioscience Association…
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
On Aug. 4, 2014, the Allen Institute for Brain Science, California Institute of Technology, New York University School…
On Jul. 29, 2014, Amgen announced closure of former Boulder-based Synergen LakeCentre facility. Amgen acquired Boulder-based Synergen in…
On Jul. 29, 2014, Amgen announced the closure of facilities in Seattle and Bothell which resulted in the…
On Jul. 1, 2014, Genentech entered into an agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company…
On Jun. 28, 2014, The Burnham Institute for Medical Research announced a record $275 million anonymous to helping…
On Apr. 14, 2014, Stanford Medicine researchers announced a study that found a gene variant puts women at…
On Feb. 3, 2014, Thermo Fisher announced it had completed its acquisition of Life Technologies for $76.13 in…
On Jan. 13, 2014, Gary K. Michelson, a retired orthopaedic spinal surgeon whose groundbreaking work generated more than…
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
On Sept. 9, 2013 Genentech announced that Richard Scheller, Ph.D., Executive VP, Research and Early Development, was a…
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
On Jun. 20, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
On Apr. 3, 2013, scientists announced they had decoded the genome of the western painted turtle, one of…
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had approved Genentech’s licensed ado-trastuzumab…
On Feb. 7, 2023, scientists from the National Oceanic and Atmospheric Administration (NOAA) Fisheries’ tissue library announced they…
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…